2023 Q2 Form 10-Q Financial Statement

#000095017023021182 Filed on May 11, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $90.01M $90.66M $81.90M
YoY Change 19.7% 10.7% 8.55%
Cost Of Revenue $45.00M $43.59M $43.27M
YoY Change 13.55% 0.73% 15.63%
Gross Profit $45.01M $47.07M $38.63M
YoY Change 26.56% 21.87% 1.57%
Gross Profit Margin 50.01% 51.92% 47.16%
Selling, General & Admin $25.46M $27.69M $27.37M
YoY Change -1.03% 1.18% 9.93%
% of Gross Profit 56.55% 58.83% 70.86%
Research & Development $3.257M $3.200M $3.068M
YoY Change -10.47% 4.3% 41.32%
% of Gross Profit 7.24% 6.8% 7.94%
Depreciation & Amortization $2.400M $6.610M $7.850M
YoY Change 0.0% -15.8% -20.03%
% of Gross Profit 5.33% 14.04% 20.32%
Operating Expenses $33.64M $35.71M $35.35M
YoY Change -1.78% 1.0% 1.85%
Operating Profit $11.37M $11.37M $3.275M
YoY Change 763.63% 247.08% -1.33%
Interest Expense $16.19M $15.77M -$12.50M
YoY Change 25.75% -226.17% -201.98%
% of Operating Profit 142.36% 138.74% -381.68%
Other Income/Expense, Net -$3.000K $0.00
YoY Change -121.43% -100.0%
Pretax Income -$4.498M -$4.213M -$9.225M
YoY Change -59.29% -54.33% -35.22%
Income Tax $200.0K $300.0K $400.0K
% Of Pretax Income
Net Earnings -$4.680M -$4.508M -$9.580M
YoY Change -58.26% -52.94% -35.51%
Net Earnings / Revenue -5.2% -4.97% -11.7%
Basic Earnings Per Share -$0.11 -$0.11 -$0.22
Diluted Earnings Per Share -$0.11 -$0.11 -$224.4K
COMMON SHARES
Basic Shares Outstanding 42.94M 42.92M 42.69M
Diluted Shares Outstanding 42.96M 42.92M 42.69M

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $20.90M $26.35M $38.40M
YoY Change -44.33% -31.4% -19.67%
Cash & Equivalents $20.90M $26.35M $38.40M
Short-Term Investments
Other Short-Term Assets $1.345M $1.271M $16.75M
YoY Change 16.45% -92.41% 31.05%
Inventory
Prepaid Expenses $15.29M $16.91M
Receivables $107.8M $102.3M $98.95M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $145.3M $146.8M $154.1M
YoY Change 1.52% -4.73% 6.86%
LONG-TERM ASSETS
Property, Plant & Equipment $18.78M $20.39M $20.04M
YoY Change -4.37% 1.76% -14.18%
Goodwill $391.1M $391.5M
YoY Change 0.19%
Intangibles $43.49M $45.12M
YoY Change -17.72%
Long-Term Investments
YoY Change
Other Assets $8.931M $8.963M $8.395M
YoY Change 7.4% 6.77% 175.16%
Total Long-Term Assets $473.8M $476.7M $478.9M
YoY Change 0.56% -0.47% -9.32%
TOTAL ASSETS
Total Short-Term Assets $145.3M $146.8M $154.1M
Total Long-Term Assets $473.8M $476.7M $478.9M
Total Assets $619.2M $623.5M $633.0M
YoY Change 0.79% -1.5% -5.85%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $29.79M $32.33M $32.83M
YoY Change 3.57% -1.51% 2.24%
Accrued Expenses $6.966M $6.730M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $289.5M $3.000M $3.000M
YoY Change 9549.7% 0.0% 0.0%
Total Short-Term Liabilities $329.3M $45.64M $39.98M
YoY Change 833.6% 14.16% 4.33%
LONG-TERM LIABILITIES
Long-Term Debt $243.9M $527.4M $510.3M
YoY Change -52.45% 3.36% 3.23%
Other Long-Term Liabilities $1.737M $2.655M $8.533M
YoY Change -76.19% -68.89% -13.71%
Total Long-Term Liabilities $245.7M $530.1M $510.3M
YoY Change -52.78% 3.88% 1.21%
TOTAL LIABILITIES
Total Short-Term Liabilities $329.3M $45.64M $39.98M
Total Long-Term Liabilities $245.7M $530.1M $510.3M
Total Liabilities $592.2M $592.6M $565.8M
YoY Change 5.26% 4.74% 2.83%
SHAREHOLDERS EQUITY
Retained Earnings -$368.3M -$363.6M
YoY Change 9.37%
Common Stock $393.8M $392.9M
YoY Change 1.36%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $26.92M $30.89M $67.23M
YoY Change
Total Liabilities & Shareholders Equity $619.2M $623.5M $633.0M
YoY Change 0.79% -1.5% -5.85%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income -$4.680M -$4.508M -$9.580M
YoY Change -58.26% -52.94% -35.51%
Depreciation, Depletion And Amortization $2.400M $6.610M $7.850M
YoY Change 0.0% -15.8% -20.03%
Cash From Operating Activities $20.00K -$3.046M -$3.646M
YoY Change -99.64% -16.46% 29.52%
INVESTING ACTIVITIES
Capital Expenditures $4.034M $2.072M $2.968M
YoY Change -190.43% -30.19% -3.89%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$4.034M -$2.072M -$2.968M
YoY Change -9.57% -30.19% -3.89%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.489M -1.283M -1.281M
YoY Change 9.65% 0.16% -147.13%
NET CHANGE
Cash From Operating Activities 20.00K -3.046M -3.646M
Cash From Investing Activities -4.034M -2.072M -2.968M
Cash From Financing Activities -1.489M -1.283M -1.281M
Net Change In Cash -5.503M -6.284M -8.065M
YoY Change 1759.12% -22.08% 137.7%
FREE CASH FLOW
Cash From Operating Activities $20.00K -$3.046M -$3.646M
Capital Expenditures $4.034M $2.072M $2.968M
Free Cash Flow -$4.014M -$5.118M -$6.614M
YoY Change -140.2% -22.62% 12.04%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001752474
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-38789
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
KLDiscovery Inc.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
61-1898603
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
9023 Columbine Road
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Eden Prairie
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
MN
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
55347
CY2023Q1 dei City Area Code
CityAreaCode
703
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
288-3380
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
42936803
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
26345000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
32629000
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4247000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
5403000
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
102289000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
95727000
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
16911000
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
10726000
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
1271000
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
1175000
CY2023Q1 us-gaap Assets Current
AssetsCurrent
146816000
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
140257000
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
82184000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
79958000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
20388000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
19840000
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
10657000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
12412000
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
45122000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
46862000
CY2023Q1 us-gaap Goodwill
Goodwill
391537000
CY2022Q4 us-gaap Goodwill
Goodwill
391114000
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
8963000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
8957000
CY2023Q1 us-gaap Assets
Assets
623483000
CY2022Q4 us-gaap Assets
Assets
619442000
CY2023Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
3000000
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
3000000
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
32333000
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
25009000
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6730000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
7850000
CY2023Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
3577000
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
4536000
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
45640000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
40395000
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
527447000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
524529000
CY2023Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
7910000
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
7793000
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8946000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
10340000
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2655000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2694000
CY2023Q1 us-gaap Liabilities
Liabilities
592598000
CY2022Q4 us-gaap Liabilities
Liabilities
585751000
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
42936803
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
42936803
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
42920136
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
42920136
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
4000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
4000
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
392854000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
391977000
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-363649000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-359141000
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1676000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
851000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
30885000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
33691000
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
623483000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
619442000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
90659000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
81898000
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
43587000
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
43272000
CY2023Q1 us-gaap Gross Profit
GrossProfit
47072000
CY2022Q1 us-gaap Gross Profit
GrossProfit
38626000
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17301000
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
16525000
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3200000
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3068000
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
10391000
CY2022Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
10844000
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4813000
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4914000
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
35705000
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
35351000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
11367000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
3275000
CY2023Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-191000
CY2022Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-191000
CY2023Q1 us-gaap Interest Expense
InterestExpense
15771000
CY2022Q1 us-gaap Interest Expense
InterestExpense
12691000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4213000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9225000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
295000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
355000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-4508000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-9580000
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
825000
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2140000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
825000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-2140000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3683000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-11720000
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
42686216
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
42686216
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
33691000
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.22
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.22
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
42920321
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
42920321
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-6284000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
877000
CY2023Q1 us-gaap Cumulative Translation Adjustment Net Of Tax Period Increase Decrease
CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease
825000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-4508000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
30885000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
77854000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1098000
CY2022Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-2140000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-9580000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
67232000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-4508000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-9580000
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6610000
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7850000
CY2023Q1 us-gaap Paid In Kind Interest
PaidInKindInterest
5156000
CY2022Q1 us-gaap Paid In Kind Interest
PaidInKindInterest
4860000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
833000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1062000
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
797000
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
827000
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
118000
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
185000
CY2022Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
9000
CY2023Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-191000
CY2022Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-191000
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
7186000
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
6822000
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
7018000
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
6190000
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3318000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
5631000
CY2023Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-975000
CY2022Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-1287000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3046000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3646000
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2072000
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2968000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2072000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2968000
CY2023Q1 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
533000
CY2022Q1 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
531000
CY2023Q1 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
750000
CY2022Q1 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
750000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1283000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1281000
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
117000
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-170000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-8065000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
32629000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
46468000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
26345000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
38403000
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
10842000
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
7876000
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
263000
CY2022Q4 us-gaap Debt Current
DebtCurrent
3000000
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
60000
CY2023Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
751000
CY2022Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1000
CY2023Q1 us-gaap Number Of Countries In Which Entity Operates
NumberOfCountriesInWhichEntityOperates
16
CY2023Q1 kld Number Of Data Centers
NumberOfDataCenters
9
CY2023Q1 kld Number Of Data Recovery Labs
NumberOfDataRecoveryLabs
13
CY2023Q1 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2018-08-02
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Use of estimates</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts and disclosures in the condensed consolidated financial statements. Although actual results could differ from those estimates, management does not believe that such differences would be material.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Significant estimates include, but are not limited to, the allowance for doubtful accounts, determining the fair values of assets acquired and liabilities assumed, including the recoverability and useful lives of property and equipment, intangible assets, and other long-lived assets, the evaluation of goodwill for impairment, the valuation and realization of deferred income taxes, the fair value of the Company’s common stock, and stock option awards.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
CY2023Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2023Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
3000000
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
3000000
CY2023Q1 us-gaap Depreciation
Depreciation
2300000
CY2022Q1 us-gaap Depreciation
Depreciation
2400000
CY2023Q1 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
1160000
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3900000
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5000000.0
CY2021Q4 us-gaap Number Of Reporting Units
NumberOfReportingUnits
1
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
90659000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
81898000
CY2022Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
1278000
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
530447000
CY2023Q1 us-gaap Contingent Consideration Classified As Equity Fair Value Disclosure
ContingentConsiderationClassifiedAsEquityFairValueDisclosure
0
CY2022 kld Settled Earnout And Issued Of Common Shares
SettledEarnoutAndIssuedOfCommonShares
128596
CY2023Q1 kld Fair Value Of Warrants
FairValueOfWarrants
400000
CY2022Q4 kld Fair Value Of Warrants
FairValueOfWarrants
600000
CY2023Q1 kld Operating And Capital Lease Agreements Lease Expiring Year
OperatingAndCapitalLeaseAgreementsLeaseExpiringYear
2029
CY2023Q1 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
1686000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
5877000
CY2023Q1 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
164000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
6149000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
3170000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1508000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
361000
CY2023Q1 kld Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
293000
CY2023Q1 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
1850000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
17357000
CY2023Q1 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
57000
CY2023Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1681000
CY2023Q1 us-gaap Finance Lease Liability
FinanceLeaseLiability
1793000
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
15676000
CY2023Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
541283000
CY2022Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
539558000
CY2023Q1 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
9676000
CY2022Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
10751000
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
527529000
CY2023Q1 us-gaap Debt Current
DebtCurrent
3000000
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
527447000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
524529000
CY2023Q1 us-gaap Debt Instrument Maturity Date Description
DebtInstrumentMaturityDateDescription
The Amended 2021 Credit Agreement matures on February 8, 2026, unless the Debentures are outstanding six months prior to the December 19, 2024 maturity date thereof, in which case the Amended 2021 Credit Agreement matures on June 19, 2024.
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.4290
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0162
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
833000
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1062000
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Common Stock Voting Rights
CommonStockVotingRights
one vote for each share
CY2023Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
0
CY2022Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
0
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
300000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
400000
CY2023Q1 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-0.071
CY2022Q1 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-0.043
CY2023Q1 kld Number Of Letters Of Credit
NumberOfLettersOfCredit
2
CY2023Q1 kld Letters Of Credit As Additional Security For Lease Guarantees
LettersOfCreditAsAdditionalSecurityForLeaseGuarantees
600000

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
kld-20230331_def.xml Edgar Link unprocessable
0000950170-23-021182-index-headers.html Edgar Link pending
0000950170-23-021182-index.html Edgar Link pending
0000950170-23-021182.txt Edgar Link pending
0000950170-23-021182-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
kld-20230331.htm Edgar Link pending
kld-20230331.xsd Edgar Link pending
kld-ex31_1.htm Edgar Link pending
kld-ex31_2.htm Edgar Link pending
kld-ex32_1.htm Edgar Link pending
kld-ex32_2.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
kld-20230331_cal.xml Edgar Link unprocessable
kld-20230331_pre.xml Edgar Link unprocessable
kld-20230331_lab.xml Edgar Link unprocessable
kld-20230331_htm.xml Edgar Link completed
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending